Murat Duranay

2.7k total citations · 1 hit paper
115 papers, 1.7k citations indexed

About

Murat Duranay is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Murat Duranay has authored 115 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Nephrology, 35 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Murat Duranay's work include Dialysis and Renal Disease Management (35 papers), Muscle and Compartmental Disorders (18 papers) and Renal and Vascular Pathologies (7 papers). Murat Duranay is often cited by papers focused on Dialysis and Renal Disease Management (35 papers), Muscle and Compartmental Disorders (18 papers) and Renal and Vascular Pathologies (7 papers). Murat Duranay collaborates with scholars based in Türkiye, United States and Romania. Murat Duranay's co-authors include Mehmet Kanbay, Richard J. Johnson, Alper Azak, Bülent Huddam, Duk‐Hee Kang, Miguel A. Lanaspa, Laura Gabriela Sánchez‐Lozada, Carlos A. Roncal-Jiménez, Christina Cicerchi and George F. Schreiner and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Murat Duranay

106 papers receiving 1.6k citations

Hit Papers

Uric Acid Induces Hepatic Steatosis by Generation of Mito... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murat Duranay Türkiye 16 778 442 360 340 307 115 1.7k
J.L. Teruel Spain 26 916 1.2× 439 1.0× 561 1.6× 177 0.5× 168 0.5× 137 2.5k
Angel de Francisco Spain 15 610 0.8× 201 0.5× 162 0.5× 225 0.7× 137 0.4× 19 1.7k
Martin Busch Germany 22 686 0.9× 194 0.4× 220 0.6× 332 1.0× 138 0.4× 92 2.0k
Alberto Martínez‐Castelao Spain 27 1.4k 1.8× 233 0.5× 600 1.7× 384 1.1× 143 0.5× 78 2.7k
Władysław Sułowicz Poland 26 1.1k 1.4× 171 0.4× 385 1.1× 195 0.6× 103 0.3× 157 2.2k
Yoon-Goo Kim South Korea 17 683 0.9× 203 0.5× 286 0.8× 111 0.3× 198 0.6× 63 1.4k
R. Romero Spain 28 960 1.2× 344 0.8× 702 1.9× 662 1.9× 151 0.5× 152 2.7k
Andrew Z. Fenves United States 21 733 0.9× 241 0.5× 314 0.9× 139 0.4× 105 0.3× 91 2.1k
Vaidyanathapuram S. Balakrishnan United States 20 1.1k 1.4× 410 0.9× 331 0.9× 116 0.3× 90 0.3× 43 2.0k
Gerard Smits United States 28 1.8k 2.3× 357 0.8× 504 1.4× 318 0.9× 973 3.2× 48 3.1k

Countries citing papers authored by Murat Duranay

Since Specialization
Citations

This map shows the geographic impact of Murat Duranay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Duranay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Duranay more than expected).

Fields of papers citing papers by Murat Duranay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Duranay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Duranay. The network helps show where Murat Duranay may publish in the future.

Co-authorship network of co-authors of Murat Duranay

This figure shows the co-authorship network connecting the top 25 collaborators of Murat Duranay. A scholar is included among the top collaborators of Murat Duranay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murat Duranay. Murat Duranay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elçik, Deniz, et al.. (2024). Platelet activating factor acetylhydrolase is associated with cardiac valvular calcification in dialysis patients. SHILAP Revista de lepidopterología. 49(2). 274–282.
2.
Duranay, Murat, et al.. (2023). The Relationship Between Vascular Access Type and Sleep Quality, Anxiety, Depression in Hemodialysis Patients. SHILAP Revista de lepidopterología. 32(2). 160–167. 2 indexed citations
3.
Azak, Alper, et al.. (2021). Serum undercarboxylated osteocalcin levels are related to bone disease in hemodialysis and peritoneal dialysis patients. The European Research Journal. 7(3). 225–234. 1 indexed citations
4.
Oğuz, Ebru Gök, et al.. (2020). The reliability and success of peritoneal dialysis during the COVID‐19 pandemic. Seminars in Dialysis. 34(2). 147–156. 24 indexed citations
5.
Özcan, Oğuzhan, et al.. (2019). Serum Neuron Specific Enolase and S-100B Levels in Hemodialysis and Peritoneal Dialysis Patients. 35(2). 83–87. 3 indexed citations
6.
Duranay, Murat, et al.. (2016). Evaluation of prolidase activity in uremic bone disease. Turkish Journal of Biochemistry. 42(1). 23–29.
7.
Bıtık, Berivan, et al.. (2015). Serum uric acid levels in patients with Familial Mediterranean Fever and healthy controls. Pediatric Rheumatology. 13(S1). 1 indexed citations
8.
Bavbek, Nüket, et al.. (2013). Correlation between iron stores and QTc dispersion in chronic ambulatory peritoneal dialysis patients. Renal Failure. 36(2). 187–190. 11 indexed citations
9.
Azak, Alper, et al.. (2013). Bone Morphogenetic Protein-7 and disease progression in renal amyloidosis patients. Renal Failure. 35(8). 1112–1115. 4 indexed citations
10.
Lanaspa, Miguel A., Laura Gabriela Sánchez‐Lozada, Christina Cicerchi, et al.. (2012). Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress. Journal of Biological Chemistry. 287(48). 40732–40744. 572 indexed citations breakdown →
11.
Huddam, Bülent, et al.. (2012). Additive Effectiveness of Everolimus Plus Tamoxifen Therapy in Treatment of Encapsulating Peritoneal Sclerosis. Renal Failure. 34(3). 387–389. 15 indexed citations
12.
Kanbay, Mehmet, Bülent Huddam, Alper Azak, et al.. (2011). A Randomized Study of Allopurinol on Endothelial Function and Estimated Glomular Filtration Rate in Asymptomatic Hyperuricemic Subjects with Normal Renal Function. Clinical Journal of the American Society of Nephrology. 6(8). 1887–1894. 198 indexed citations
13.
Duranay, Murat, et al.. (2010). Importance of jak-2 gene mutation in the diagnosis of polycythemia vera: a case report and review of the literature -. Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy. 6(1). 35–38. 1 indexed citations
14.
Ünverdi, Selman, et al.. (2010). Gastroduodenal Plasmacytoma Presenting with Jaundice. Southern Medical Journal. 103(2). 159–161. 3 indexed citations
15.
Bavbek, Nüket, Hatice Akay, Burak Uz, et al.. (2010). The Effects of L-Carnitine Therapy on Respiratory Function Tests in Chronic Hemodialysis Patients. Renal Failure. 32(2). 157–161. 8 indexed citations
16.
Koçak, Erdem, et al.. (2010). MEFV Gene Mutations in a Patient with Eosinophilic Gastroenteritis. Southern Medical Journal. 103(11). 1170–1172. 4 indexed citations
17.
Altay, Mustafa, et al.. (2008). Duration of Renal Failure as Risk Factor for Conjunctival Squamous Metaplasia. Acta Cytologica. 52(3). 309–312. 9 indexed citations
18.
Duranay, Murat, et al.. (2006). Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients. Nephrology Dialysis Transplantation. 21(11). 3211–3214. 75 indexed citations
19.
Üstün, İhsan, et al.. (2005). Brucella Glomerulonephritis: Case Report and Review of the Literature. Southern Medical Journal. 98(12). 1216–1217. 10 indexed citations
20.
Yılmaz, Fatma Meriç, et al.. (2004). Hemodiyaliz ve Periton Diyalizi Hastalarında Serum Malondialdehit Düzeyleri ve Oksidasyona Yatkınlık. Turkiye Klinikleri Tip Bilimleri Dergisi. 24(4). 316–322.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026